ProKidney Corp.
PROK
$1.08
$0.054.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 76.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.00K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 76.00K | -- | -- | -- | -- |
| SG&A Expenses | 50.76M | 40.58M | 42.60M | 42.40M | 44.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 178.43M | 150.99M | 153.96M | 150.72M | 151.52M |
| Operating Income | -178.35M | -150.99M | -153.96M | -150.72M | -151.52M |
| Income Before Tax | -163.93M | -136.09M | -133.77M | -129.10M | -129.45M |
| Income Tax Expenses | -598.00K | 491.00K | 3.75M | 4.77M | 6.00M |
| Earnings from Continuing Operations | -163.34 | -136.58 | -137.51 | -133.87 | -135.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 102.15M | 90.97M | 98.83M | 98.58M | 99.98M |
| Net Income | -61.19M | -45.61M | -38.68M | -35.30M | -35.47M |
| EBIT | -178.35M | -150.99M | -153.96M | -150.72M | -151.52M |
| EBITDA | -172.92M | -145.99M | -149.44M | -146.60M | -147.67M |
| EPS Basic | -0.63 | -0.55 | -0.59 | -0.57 | -0.57 |
| Normalized Basic EPS | 0.07 | 0.15 | 0.24 | 0.29 | 0.31 |
| EPS Diluted | -0.63 | -0.55 | -0.59 | -0.57 | -0.57 |
| Normalized Diluted EPS | 0.07 | 0.15 | 0.24 | 0.29 | 0.31 |
| Average Basic Shares Outstanding | 391.24M | 325.19M | 260.61M | 249.27M | 249.86M |
| Average Diluted Shares Outstanding | 391.24M | 325.19M | 260.61M | 249.27M | 249.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |